BIOTECHNOLOGY VALUE FUND L P 13D/13G Filings for Zymeworks Inc. (ZYME)

BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Zymeworks Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-11-14
4:27 pm
Purchase
2024-09-3013GZymeworks Inc.
ZYME
BIOTECHNOLOGY VALUE FUND L P4,607,935
6.500%
4,607,935increase
(New Position)
Filing